DrugPatentWatch

DrugPatentWatch Archives

You are currently viewing the 2008 archives
Click here to return to the current data set

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Tradename: AMIODARONE HYDROCHLORIDE

Summary for Tradename: AMIODARONE HYDROCHLORIDE

Patents:0
Applicants:22
NDAs:25
drug
patent expirations by year for
 AMIODARONE HYDROCHLORIDE

Clinical Trials for: AMIODARONE HYDROCHLORIDE

Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac Surgery
Status: Active, not recruiting Condition: Atrial Fibrillation

Effect of Prophylaxy of Amiodarone and Propranolol and Amiodarone With Propranolol in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft
Status: Completed Condition: Atrial Fibrillation

Concentrations of Amiodarone in Fat Tissue During Chronic Treatment
Status: Completed Condition: Arrhythmia; Atrial Fibrillation; Atrial Flutter

Withdrawal Versus Continuation of Amiodarone in Successfully Treated Patients With Persistent Atrial Fibrillation
Status: Completed Condition: Persistent Atrial Fibrillation

Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia
Status: Terminated Condition: Defibrillators, Implantable; Tachycardia, Ventricular

Amiodarone for the Prevention of Reperfusion Ventricular Fibrillation
Status: Completed Condition: Other Intraoperative Cardiac Functional Disturbances During Cardiac Surgery

Safety and Efficacy of Oral Versus Intravenous Amiodarone in the Treatment of AF
Status: Not yet recruiting Condition: Atrial Fibrillation

A Phase III Superiority Study of Vernakalant vs Amiodarone in Subjects With Recent Onset Atrial Fibrillation
Status: Completed Condition: Atrial Fibrillation

Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention of Death
Status: Not yet recruiting Condition: Chagas Cardiomyopathy; Non-sustained Ventricular Tachycardia; At Least 10 Points in Rassi Risk Score for Death

Bioavailability of Dabigatran and Amiodarone After Multiple Oral Administrations of Dabigatran Etexilate With or Without Amiodarone as Single Dose in Healthy Male and Female Volunteers
Status: Completed Condition: Healthy

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Exclusivity Expiration
Zydus Pharms Usa Inc
AMIODARONE HYDROCHLORIDE
amiodarone hydrochloride
TABLET; ORAL079029Sep 16, 2008RXNo<disabled><disabled>
Wockhardt
AMIODARONE HYDROCHLORIDE
amiodarone hydrochloride
INJECTABLE; INJECTION077610Oct 30, 2008RXNo<disabled><disabled>
Wockhardt
AMIODARONE HYDROCHLORIDE
amiodarone hydrochloride
INJECTABLE; INJECTION077834Oct 30, 2008RXNo<disabled><disabled>
Teva Pharms
AMIODARONE HYDROCHLORIDE
amiodarone hydrochloride
TABLET; ORAL074739Nov 30, 1998RXNo<disabled><disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc